Inhibition of bovine brain aldehyde reductase by anticonvulsant compounds in vitro.
D000445:Aldehyde Oxidoreductases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology; D001921:Brain / Q000201:enzymology*; D002417:Cattle; D005013:Ethosuximide / Q000494:pharmacology; D006827:Hydantoins / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007536:Isomerism; D007700:Kinetics; D008618:Mephobarbital / Q000494:pharmacology; D009249:NADP; D010424:Pentobarbital / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D013053:Spectrophotometry; D013388:Succinimides / Q000494:pharmacology; D014293:Trimethadione / Q000494:pharmacology
D000927:Anticonvulsants; D001463:Barbiturates; D006827:Hydantoins; D013388:Succinimides; D009249:NADP; D008618:Mephobarbital; D005013:Ethosuximide; D010672:Phenytoin; D000445:Aldehyde Oxidoreductases; D000654:Amobarbital; D010424:Pentobarbital; D014293:Trimethadione; D010634:Phenobarbital